republic-os/legislation/us/states/in/2021/hb-1225.md

type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags

type	title	description	jurisdiction	legislature	session	identifier	citation	classification	subjects	status	primary_sponsors	version_count	action_count	vote_count	first_action	last_action	source	source_identifier	source_url	source_hash	vintage	source_snapshot	retrieved_at	confidence	tags
Bill	Opioid treatment programs.	Requires an opioid treatment program to obtain prior authorization from the division of mental health and addiction (division) for patients receiving more than 14 days of opioid treatment medication from an opioid treatment program unless otherwise prescribed by the division. Allows the state opioid treatment authority (authority) to: (1) take certain remedial actions; and (2) impose a civil penalty of up to $10,000; in response to certain violations concerning the operation of an opioid treatment program. Specifies that the authority may issue a civil penalty for each violation found by the authority. Requires the division to report certain findings to the general assembly not later than April 1 of each year. Requires certain information to be provided to the division for the purpose of completing specified reporting requirements.	us/states/in	Indiana General Assembly	2021	HB 1225	Indiana HB 1225 (2021)	bill	CIVIL ACTIONS Penalties DRUGS Treatment of Drug and Other Substance Abuse HUMAN SERVICES	enacted	Ann Vermilion Ed Charbonneau Michael Crider Vaneta Becker	4	26	1	2021-01-14	2021-04-29	openstates	ocd-bill/e9576a1f-35c4-4dc7-bacb-94045bbc263f	http://iga.in.gov/legislative/2021/bills/house/1225	42936a22d33fb5efee6a62f2b1562b94fa250e3c8c3c3cc86bb46540b2901580	2026-07-01	https://data.openstates.org/daily/2026-07-01/public.pgdump	2026-07-06	reported	legislation bill us-in

Indiana HB 1225 (2021) — Opioid treatment programs.

Requires an opioid treatment program to obtain prior authorization from the division of mental health and addiction (division) for patients receiving more than 14 days of opioid treatment medication from an opioid treatment program unless otherwise prescribed by the division. Allows the state opioid treatment authority (authority) to: (1) take certain remedial actions; and (2) impose a civil penalty of up to $10,000; in response to certain violations concerning the operation of an opioid treatment program. Specifies that the authority may issue a civil penalty for each violation found by the authority. Requires the division to report certain findings to the general assembly not later than April 1 of each year. Requires certain information to be provided to the division for the purpose of completing specified reporting requirements.

Version chain

The bill's text revisions, in order — the diff chain from filing to enrollment.

1. Enrolled House Bill (H) (committee substitute) — source
2. House Bill (H) (committee substitute) — source
3. House Bill (S) (committee substitute) — source
4. Introduced House Bill (H) (committee substitute) — source

Votes

• HB 1225 - Crider - 3rd Reading — 31–17 (pass) · upper

Sponsors

• Ann Vermilion — primary (person)
• Ed Charbonneau — primary (person)
• Michael Crider — primary (person)
• Vaneta Becker — primary (person)
• Edward Clere — coauthor (person)
• Lonnie Randolph — cosponsor (person)
• Robin Shackleford — coauthor (person)
• Shelli Yoder — cosponsor (person)
• Steven Davisson — coauthor (person)

Timeline

The legislative action history — every referral, reading, and vote.

• 2021-01-14 Coauthored by Representative Clere
• 2021-01-14 Authored by Representative Vermilion
• 2021-01-14 First reading: referred to Committee on Public Health reading-1, referral-committee
• 2021-01-26 Committee report: do pass, adopted committee-passage
• 2021-01-28 Second reading: ordered engrossed reading-2
• 2021-01-28 Representative Davisson added as coauthor
• 2021-01-28 Representative Shackleford added as coauthor
• 2021-02-01 Third reading: passed; Roll Call 25: yeas 96, nays 1 passage, reading-3
• 2021-02-01 Senate sponsor: Senator Crider
• 2021-02-02 Referred to the Senate
• 2021-02-18 First reading: referred to Committee on Health and Provider Services reading-1, referral-committee
• 2021-03-01 Senator Charbonneau added as second sponsor
• 2021-03-11 Committee report: do pass, adopted committee-passage
• 2021-03-11 Senator Becker added as third sponsor
• 2021-03-11 Senator Yoder added as cosponsor
• 2021-03-15 Second reading: ordered engrossed reading-2
• 2021-03-18 Placed back on second reading reading-2
• 2021-03-18 Senator Randolph added as cosponsor
• 2021-04-12 Reread second time: ordered engrossed reading-2
• 2021-04-13 Third reading: passed; Roll Call 419: yeas 31, nays 17 passage, reading-3
• 2021-04-14 Returned to the House without amendments
• 2021-04-16 Signed by the Speaker
• 2021-04-23 Signed by the President Pro Tempore
• 2021-04-28 Signed by the President of the Senate
• 2021-04-29 Public Law 181
• 2021-04-29 Signed by the Governor executive-signature

Source

OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/e9576a1f-35c4-4dc7-bacb-94045bbc263f. Confidence: reported (aggregated from official Indiana legislature records).